Clinical trial
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue…
NCT00346125 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00346125 |
|---|---|
| Title | PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma |
| Official title | An Evaluation of PET/CT Imaging as a Predictor of Disease Free Survival Following Neo-Adjuvant Chemotherapy for Soft Tissue Sarcoma |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | pegfilgrastim, doxorubicin hydrochloride, ifosfamide, pegylated liposomal doxorubicin hydrochloride, conventional surgery, fludeoxyglucose F 18 |
| Enrollment | 70 |
| Start date | Apr 10, 2006 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2022 |
| First posted | Jun 29, 2006 |
| Last update posted | Dec 15, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: